Juvéderm Volbella® XC is formulated with VYCROSS®, a proprietary filler technology from Allergan that blends different molecular weights of hyaluronic acid. This unique blending contributes to the gel's duration with most patients experiencing results that last through one year. The product is customized with a lower hyaluronic acid concentration (15 mg/mL) which makes it a softer, smoother gel, ideal for use around the delicate mouth area. Yet it still provides the long-lasting results health care providers have come to expect from the Juvéderm collection of fillers.
Several clinical trials have demonstrated the safety and effectiveness of Juvéderm Volbella® XC including one pivotal study in the United States where 168 subjects were treated with the injectable gel. Approximately two-thirds of the group showed improvement in lip fullness and perioral lines that lasted through one year. The most common side effects were temporary responses at the treatment site, including swelling, tenderness, bruising, redness and itching, but most of these issues resolved themselves within 30 days.
A leading dermatologist, Dr. Timothy Jochen specializes in medical and cosmetic dermatology and cosmetic surgery procedures. He is one of the top facial filler and Botox injectors in the nation. Dr. Jochen is also an Associate Professor of Dermatology at the University of Southern California in Los Angeles. He also is a Castle Connolly Top Doctor as voted by his peers. Contour Dermatology & Cosmetic Surgery Center has four Southern California locations.
To learn more about Contour Dermatology or Juvéderm Volbella® XC, visit https://contourderm.com/volbella/.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/juvederm-volbella-xc--fda-approved-lip-volumizer-and-mouth-line-softener-now-available-at-contour-dermatology--cosmetic-surgery-center-300344914.html
SOURCE Contour Dermatology & Cosmetic Surgery Center